Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.

Kim JW, Boo SJ, Ye BD, Kim CL, Yang SK, Kim J, Kim SA, Park SH, Park SK, Yang DH, Jung KW, Kim KJ, Byeon JS, Myung SJ, Kim JH.

J Crohns Colitis. 2014 Jul;8(7):693-701. doi: 10.1016/j.crohns.2013.12.014. Epub 2014 Jan 7.

PMID:
24405983
2.

Cytomegalovirus Infection in Ulcerative Colitis is Related to Severe Inflammation and a High Count of Cytomegalovirus-positive Cells in Biopsy Is a Risk Factor for Colectomy.

Zagórowicz E, Bugajski M, Wieszczy P, Pietrzak A, Magdziak A, Mróz A.

J Crohns Colitis. 2016 Oct;10(10):1205-11. doi: 10.1093/ecco-jcc/jjw071. Epub 2016 Mar 12.

PMID:
26971053
3.

[Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].

Özkarata E, Özbek ÖA, Avkan Oğuz V, Sayıner AA.

Mikrobiyol Bul. 2016 Jan;50(1):44-52. Turkish. Erratum in: Mikrobiyol Bul. 2016 Apr;50(2):352. Özkarataş, Emre [corrected to Özkarata, Emre].

4.

Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.

Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, Hasegawa S, Sakai Y, Chiba T.

Inflamm Bowel Dis. 2007 Dec;13(12):1516-21.

PMID:
17828781
5.

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.

Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M.

Bone Marrow Transplant. 2002 Apr;29(7):599-606.

7.
8.

Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.

Nagata N, Kobayakawa M, Shimbo T, Hoshimoto K, Yada T, Gotoda T, Akiyama J, Oka S, Uemura N.

World J Gastroenterol. 2011 Mar 7;17(9):1185-91. doi: 10.3748/wjg.v17.i9.1185.

9.

Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.

Ksouri H, Eljed H, Greco A, Lakhal A, Torjman L, Abdelkefi A, Ben Othmen T, Ladeb S, Slim A, Zouari B, Abdeladhim A, Ben Hassen A.

Transpl Infect Dis. 2007 Mar;9(1):16-21.

PMID:
17313466
10.

Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.

Inokuchi T, Kato J, Hiraoka S, Suzuki H, Nakarai A, Hirakawa T, Akita M, Takahashi S, Harada K, Okada H, Yamamoto K.

World J Gastroenterol. 2014 Jan 14;20(2):509-17. doi: 10.3748/wjg.v20.i2.509.

11.

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L.

J Clin Microbiol. 2004 Mar;42(3):1142-8.

12.

[Comparison of real-time polymerase chain reaction and antigenemia assay to detect cytomegalovirus in pediatric transplants].

Farfán U MJ, Torres T JP, Vergara A A, Donoso W G, Alba G A, Paris D C, Santolaya De P ME.

Rev Chilena Infectol. 2011 Apr;28(2):113-7. doi: /S0716-10182011000200002. Epub 2011 May 5. Spanish.

13.

Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D.

J Clin Microbiol. 2008 Oct;46(10):3311-8. doi: 10.1128/JCM.00797-08. Epub 2008 Aug 27.

14.

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T.

Am J Gastroenterol. 2007 Feb;102(2):331-7. Epub 2006 Dec 11.

PMID:
17156136
15.

Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients.

Hamada Y, Nagata N, Shimbo T, Igari T, Nakashima R, Asayama N, Nishimura S, Yazaki H, Teruya K, Gatanaga H, Kikuchi Y, Akiyama J, Ohmagari N, Uemura N, Oka S.

AIDS Patient Care STDS. 2013 Jul;27(7):387-91. doi: 10.1089/apc.2013.0115. Epub 2013 Jun 25.

16.

Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.

Yoshino T, Nakase H, Matsuura M, Matsumura K, Honzawa Y, Fukuchi T, Watanabe K, Murano M, Tsujikawa T, Fukunaga K, Matsumoto T, Chiba T.

Digestion. 2011;84(1):3-9. doi: 10.1159/000321911. Epub 2011 Feb 9.

17.

Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis.

Chun J, Lee C, Kwon JE, Hwang SW, Kim SG, Kim JS, Jung HC, Im JP.

Intest Res. 2015 Jan;13(1):50-9. doi: 10.5217/ir.2015.13.1.50. Epub 2015 Jan 29.

18.

Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis.

Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM, Chambonnière ML, Garraud O, Peyrin-Biroulet L, Pozzetto B.

Am J Gastroenterol. 2011 Nov;106(11):2001-8. doi: 10.1038/ajg.2011.202. Epub 2011 Jul 26.

PMID:
21788989
19.

Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.

Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S.

Bone Marrow Transplant. 2004 Feb;33(4):431-4.

PMID:
14676775
20.

Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.

Okahara K, Nagata N, Shimada T, Joya A, Hayashida T, Gatanaga H, Oka S, Sakurai T, Uemura N, Akiyama J.

PLoS One. 2017 Sep 8;12(9):e0183951. doi: 10.1371/journal.pone.0183951. eCollection 2017.

Supplemental Content

Support Center